Rigel Pharmaceuticals
RIGL
RIGL
131 hedge funds and large institutions have $276M invested in Rigel Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 38 increasing their positions, 35 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.2% less ownership
Funds ownership: 9% → 8.8% (-0.2%)
32% less capital invested
Capital invested by funds: $407M → $276M (-$131M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
131
Holding in Top 10
–
Calls
$104K
Puts
$73K
Top Buyers
| 1 | +$4.63M | |
| 2 | +$3.3M | |
| 3 | +$2.17M | |
| 4 |
BlackRock
New York
|
+$1.76M |
| 5 |
Millennium Management
New York
|
+$1.67M |
Top Sellers
| 1 | -$6.33M | |
| 2 | -$3.27M | |
| 3 | -$2.46M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$2.4M |
| 5 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
-$2.22M |